IGF2BP2 and pancreatic adenocarcinoma: Results suggested that copy number gain of IGF2BP2 alone was an independent risk factor for worse OS (for multivariate Cox regression, HR = 2.392, 95%CI: 1.392-4.112, p<0.001) and DFS (for multivariate Cox regression, HR = 2.400, 95%CI: 1.236-4.659, p=0.010) of PAAD patients (Table 4).